KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 259 filers reported holding KARUNA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.43 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,866,000 | +62.0% | 22,863 | +107.8% | 0.00% | 0.0% |
| Q2 2023 | $2,386,000 | +8.2% | 11,001 | -9.4% | 0.00% | 0.0% |
| Q1 2023 | $2,205,000 | -3.7% | 12,143 | +4.2% | 0.00% | 0.0% |
| Q4 2022 | $2,290,000 | +99.3% | 11,657 | +128.2% | 0.00% | – |
| Q3 2022 | $1,149,000 | +4003.6% | 5,109 | +2254.4% | 0.00% | – |
| Q2 2022 | $28,000 | -84.3% | 217 | -84.6% | 0.00% | – |
| Q1 2022 | $178,000 | -73.2% | 1,407 | -72.3% | 0.00% | – |
| Q4 2021 | $665,000 | +161.8% | 5,073 | +144.4% | 0.00% | – |
| Q3 2021 | $254,000 | -41.7% | 2,076 | -45.7% | 0.00% | – |
| Q2 2021 | $436,000 | +254.5% | 3,824 | +273.8% | 0.00% | – |
| Q1 2021 | $123,000 | +623.5% | 1,023 | +501.8% | 0.00% | – |
| Q4 2020 | $17,000 | +466.7% | 170 | +254.2% | 0.00% | – |
| Q1 2020 | $3,000 | – | 48 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Pivotal bioVenture Partners Investment Advisor LLC | 782,008 | $169,578,435 | 55.90% |
| Nan Fung Group Holdings Ltd | 225,688 | $48,940,443 | 31.28% |
| Sofinnova Investments, Inc. | 1,381,149 | $299,502,161 | 19.62% |
| Paradigm Biocapital Advisors LP | 283,605 | $61,499,744 | 4.75% |
| First Light Asset Management, LLC | 208,746 | $45,266,570 | 3.55% |
| Avidity Partners Management LP | 442,200 | $95,891,070 | 3.35% |
| CATALYST PRIVATE WEALTH, LLC | 21,837 | $4,735,353 | 2.97% |
| Rock Springs Capital Management LP | 493,527 | $107,021,330 | 2.55% |
| Boxer Capital, LLC | 250,000 | $54,213 | 2.51% |
| DAFNA Capital Management LLC | 42,173 | $9,145,215 | 2.50% |